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1. Introduction 
 
The term “systems biology” appears widely in the literature and is 
defined as an emerging approach applied to biomedical and biological 
scientific research [1]. Systems biology mostly focuses on integrative 
omics data analysis, mathematical modeling, cellular components 
interactions, and quantification of dynamic responses in living 
organisms. Systems biology is typically proposed to achieve a 
quantitative biological system under study and this is often shown in 
the form of a mathematical model. A number of case studies use the 
model for capturing reporter features of the biological system and can 
hence be later used to predict cellular behaviors at different conditions 
[2]. In other cases, the modeling of the mathematical model rather 
serves as a toolbox to extract information of the biological system and 
to perform data enrichment and classification. Generally, this 
mathematical model goes hand in hand with laboratory experimental 
work. Through this, the essence combination exemplifies the core of 
systems biology and leads to gaining new insight into the fundamental 
molecular mechanisms occurring in living cells. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
In recent years, systems biology has moved towards metabolic 
engineering [3]. Metabolic engineering is a fascinating science which 
has several definitions. Most of these are mostly aimed at improving 
existing cell factories or developing new ones, which are similar to the 
use of genetic engineering to perform directed genetic manipulations 
of cell factories with the overall objective to improve their properties 
for industrial applications. Nonetheless, metabolic engineering clearly 
differentiates itself by the use of advanced analytical techniques for 
the identification of suitable targets for genetic manipulation and the 
use of mathematical models to perform in silico design of optimized 
cell factories. 
Focusing in the field of industrial biotechnology, there is much 
studied on how systems biology and metabolic engineering can impact 
the development of efficient cell factories, especially moving forward 
in improving industrial production processes and developing new 
products. In this present era, there are certainly rapid jumps towards 
the use of another type of microalgae, the cyanobacteria Arthrospira 
(formerly known as Spirulina), as sustainable cell factories. These 
bacteria are well-known to be used in the production of many 
industrial products, including high value compounds, such as healthy 
food supplements, animal feed, cosmetics and pharmaceutical 
products. In addition, Arthrospira are currently used as important 
green cell factories for biofuel production (e.g. hydrogen, bioethanol 
and biodiesel) which serve for renewable energy resources [4, 5]. 
With the advancement of high-throughput omics technologies 
and bioinformatics accompanied by systems biology and metabolic 
engineering, these processes have rapidly allowed for the obtainment 
of a more comprehensive understanding of Arthrospira cell factories. 
The basic researches of high-throughput omics technologies are 
generally focused on how metabolisms are operating at different 
environmental conditions. Therefore, integrative technologies like 
genomics, transcriptomics, proteomics, metabolomics and fluxomics 
as well as bioinformatics, which provide qualitative and/or 
quantitative information on the operation of the metabolism in a 
context of network, are playing a key role in systems biology. Besides  
these technologies, systematic techniques underlying metabolic 
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engineering for the analysis of metabolic pathways and guiding 
rational strategies for the direct improvement of cellular activity [6, 7] 
are additionally valuable. Considering all possible advanced 
technologies and tools available, there are great opportunities for 
mapping correlations between genotypes and phenotypes and gaining 
further insight into our understanding of Arthrospira. 
To show an overview of systems biology and metabolic 
engineering through industrial biotechnology for the development of 
Arthrospira cell factories, we therefore illustrate the entire processes as 
shown in Figure 1. Initially, the process of developing Arthrospira cell 
factories from systems biology, i.e., multi-level omics, bioinformatics 
and metabolic networks, can be used to perform fundamental analysis 
of the cells. Afterwards, such Arthrospira cell factories are developed 
through metabolic engineering, i.e., mathematical modeling, and can 
be used to guide directed genetic manipulations. Finally, the 
developed cell factories of Arthrospira are used as workhorses for the 
industrial production process, i.e., conversion from raw materials to 
product formations.  
 
 
 
 
 
 
 
 
In the following description, we firstly review how Arthrospira 
cell factories are mainly used for industrial applications. We then 
focus on the systems biology and the metabolic engineering toolboxes 
available for Arthrospira, i.e., genome sequencing projects on different 
Arthrospira strains for which the sequence data are publicly available, 
proteomics, genome-scale metabolic network and in silico modeling as 
well as their updated status and applications. Towards the end, we 
describe the perspective and future direction of Arthrospira cell 
factories. 
 
2. Arthrospira as cell factories for industrial applications 
  
Arthrospira (Spirulina) are filamentous non-N2-fixation 
cyanobacteria in a group of cyanobacteria which naturally grow in a 
high-salt alkaline open pond system in tropical areas [8-10] and 
utilize sunlight and CO2 to produce essential chemical compounds for 
life. The genus Arthrospira  is comprised of approximately 51 strains 
within two common species, namely, Arthrospira platensis and 
Arthrospira maxima, that play an important role for  industrial 
applications [11]. Table 1 summarizes the available information of 
various important biotechnological aspects of Arthrospira strains. 
 A. platensis (Spirulina platensis) is widely used as a source for 
commercially-produced food supplements and animal feeds since the 
1970s [12]. In addition, A. platensis has been consumed as a protein 
source for many years by North Africans and Mexicans [1].  As A. 
platensis contains high amounts of healthy nutritional molecules, such 
as beta-carotene, phycocyanin, vitamins, trace minerals, and 
polyunsaturated fatty acids [13-15], it is currently promoted as 
functional foods with safe consumption and widely sold in various 
health food stores in the forms of capsules, tablets, and powders. 
Recently, A. platensis has also played an important role for a wide 
range of antioxidant products, such as antioxidant enzymes (i.e., 
superoxide dismutase (SOD), catalase (CAT), peroxidase (PX), and 
ascorbate peroxidase (APX), as well as antioxidant compounds (i.e., 
carotenoids, tocopherols, vitamin C, and glutathione) which could be 
better used against cell death induced by free radicals than chemical 
antioxidants [16-18].  
Moreover, there are many scientific articles which report the 
therapeutic benefits of this microorganism [19-22], such as invasive 
tumor  inhibition [23], the inhibition of virus replication [24], and 
the inhibition of chronic disorders [25, 26] and cancers [27, 28]. 
Furthermore, A. platensis is potentially one microalgae that is capable 
of renewable energy production, which could decrease the effects of 
global warming.  This is due to its potential to capture and convert 
CO2 and sunlight into various value-added products through cellular 
processes, e.g., photosynthesis, glycolysis, TCA cycle, and fatty acid 
and lipid biosynthesis. Hereby, A. platensis has become an attractive 
photobiological cell factory as presented in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
Among the different species of microalgae [29], A. platensis, as 
well as A. maxima, were identified as being capable of growing in 
outdoor environments at a high rate showing high total lipids and 
biodiesel yields (9.2% and 7.5%, respectively).  In particular, A. 
maxima strain CS-328 exhibited the high growth rate and showed the 
hydrogen yield by auto-fermentation among other cyanobacteria (up 
to 18% of hydrogen in the headspace) [30]. A noticeable example 
reported by Ananyev GM et al. showed that enhanced hydrogen 
production with 11-fold of hydrogen yield and 3.4-fold of hydrogen 
production rate from A. maxima was done by manipulating the 
equilibrium and thermodynamics of the hydrogenase reaction and 
removing the excreted products [31]. As described, these benefits 
correspond with other relevant nutritional value achievements from 
Arthrospira, showing the favorable industrial applications of cell 
factories.  
Figure 1. An integration of systems biology with metabolic engineering for 
advancing industrial biotechnology in order to develop efficient cell 
factories of Arthrospira. 
Figure 2. Schematic pathway diagram of the Arthrospira core metabolic 
process for the production of the chemical building blocks used as the 
precursors of high-value compounds discussed in this review. 
Abbreviations are: ADPG, ADP-glucose; G6P, glucose-6-phosphate; F6P, 
fructose-6-phosphate; FBP, fructose 1, 6-bisphosphate; GAP, 
glyceraldehyde phosphate; DHAP, dihydroxyacetone phosphate; 3PG, 1,3-
bisphosphoglycerate; Pyr, pyruvate; AcCoA, acetyl-CoA; FD, hydrogenase-
ferredoxin; PS I, photosystem I; PS II, photosystem II. 
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In recent years,  many efforts have been attempted to increase the 
biomass productivity of Arthrospira factories in various 
photobioreactors, such as in open raceway ponds with the biomass 
productivity of 28-46 mg L -1day-1 [32] and in various types of closed 
photobioreactors with the biomass productivity of 42.3 mg L -1day-1 
[33],  135 mg L -1day-1[34], and  220 mg L -1day-1 [35]. Furthermore, 
several strategies for the improvement of Arthrospira biomass have 
been studied and proposed including changing physical parameters, 
i.e., inoculum ages [36], temperatures and pH [37], and solar UV 
radiations [38].Besides, biomass productivity and yields have been 
further enhanced in Arthrospira cultivations during the past decade by 
changing some of the nutrients from those in the conventional 
mediums to other carbon and/or nitrogen sources [39, 40], such as 
urea, ammonium andammonium chloride as  nitrogen sources [41], as 
well as glucose and acetate as additional carbon sources in the 
photoheterotrophic culture of Arthrospira [42, 43]. However, these 
alterations of nutrients are still somewhat unproductive and 
impractical to be used in the cultivation of Arthrospira at a 
commercial scale due to the high costs of raw materials. Systems 
biology and metabolic engineering have therefore become increasingly 
significant to help identify new rational ways of enhancing the 
biomass biosynthesis rate in Arthrospira.  
3. Systems biology and metabolic engineering toolboxes for 
Arthrospira 
 
The cellular machinery complexity is always a biological challenge. 
The complex regulatory circuits occurring at different levels of 
cellular control within the cells are often a bottleneck for 
understanding living cells. To overcome this, the systems biology and 
metabolic engineering toolboxes are required.  Here, we discuss these 
toolboxes through global information from genomics and proteomics 
as well as genome-scale metabolic models available for Arthrospira. At 
the end, we describe the status of existing metabolic models for 
Arthrospira and their applications. 
 
A recent publication in 2008 of the first genome sequence of A. 
maxima strain CS-328 [44] was released by the DOE-Joint Genome 
Institute through shotgun sequencing technologies 
(http://img.jgi.doe.gov/cgi-bin/w/main.cgi), the field of 
cyanobacterial genomics that has been of growing importance to 
biological studies. In the consequent time, there were two genome 
sequences of Arthrospira available, namely, Arthrospira sp. strain PCC 
8005  and A. platensis strain Paraca,  which contained about 100 
contigs [44] and 1,000 contigs (http://img.jgi.doe.gov/cgi-
bin/w/main.cgi), respectively. So far, these current genome sequences 
are still incomplete and under functional annotation with the overall 
aim to better understand the physiology and metabolic potential of 
Arthrospira. Considering further genomic evolution events (e.g. gene 
loss or gene transfer),  this remains a big challenge [45] for the 
cyanobacterial field. 
A few years later, there was an effort by the National Institute of 
Technology and Evaluation (NITE) for a complete genome 
sequencing project. In 2010, A. platensis strain NIES-39 was 
successfully released with a complete form of a single circular genome 
[46]. This has absolutely unlocked the hidden code of cyanobacterial 
life.  
For fundamental research, A. platensis strain NIES-39 can be 
used as a reference genome for mapping, ordering and orientation of 
various contigs existing in the incomplete Arthrospira genomes. 
Moreover, it can be used for advancing comparative genomics studies, 
such as a comparative analysis of A. platensis between genomes of 
NIES-39 and C1 (PCC9438) [47]. A. platensis strain C1 
(PCC9438) is a new genome recently published in 2012 by 
Cheevadhanarak et al. from King Mongkut's University of 
Technology Thonburi, Thailand [47]. Up to date, the comparative 
studies provide a survey in the basic knowledge of Arthrospira strains 
and their metabolic diversity which yields valuable insight into 
Arthrospira metabolism.  
Regarding all possible characteristics of Arthrospira genomes 
available as listed in Table 2, the typical genome sizes are in between 
5.0-6.7 Megabases (Mb) with an average GC content of 44.3-44.8%. 
In terms of gene prediction and functional annotation using 
bioinformatics, Arthrospira genome sequences include 5,370-6,630 
protein-encoding genes and 30-45 RNA genes. Among these, 800-
1,400 protein-encoding genes correspond with the KEGG metabolic 
pathway (Table 2). For the other functional enrichment analysis, 
interestingly the Arthrospira species have abundant functions involved 
in defense mechanisms (e.g. restriction modification, group II intron, 
CRISPR, and insertion elements (ISs) [44, 46, 47]. Through the 
genomic description as mentioned above, it suggests that Arthrospira 
species are feasibly versatile cell factories at a genetic level. Table 2 
shows the status of genomics information available for the 
Arthrospira genomes. 
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 Proteomics is one of highly-studied omics technologies for 
Arthrospira in order to achieve quantitative description of protein 
expression and its changes under the influence of biological 
perturbations. Currently, there are several proteomics studies of 
Arthrospira on the cellular response to the temperature stress. For 
instance, an interesting story by Hongsthong et al. [48] presented 
differential expression studies of A. platensis proteins during cold-
induced stress. Their results showed that the up-regulated proteins in 
every subcellular fraction were involved in two-component response 
systems, DNA repairs, molecular chaperones, stress-induced proteins 
and proteins related to other biological processes (e.g. secretion 
system and nitrogen assimilation). A following study by Hongsthong 
et al. about the changes in protein expression of A. platensis was then 
examined upon exposure to high temperature [49]. Surprisingly,  it 
revealed  a number of proteins which were tolerant to high 
temperature stress and showed a relationship between  temperature 
stress as well as nitrogen and ammonia assimilation [49]. Considering 
different conditions under low- and high-temperature stresses, 
Kurdrid et al. further showed that low-temperature stress was tightly 
linked to oxidative stress and photosynthesis; temperature stress was 
also suggested to be connected with nitrogen and ammonia 
assimilation. However, there was no specific mechanism for high-
temperature stress response [50].  
 
The availability of recent genomic sequences and annotations of 
A. platensis strain C1 [47] has made it possible to reconstruct its first 
genome-scale metabolic network so-called iAK692. This first 
comprehensive reconstruction of Arthrospira metabolism was 
proposed by  the group of Klanchui et al. [51]. The genome-scale 
model was named iAK692 where AK is the name of the creator, 
Amornpan Klanchui, and 692 is the number of open reading frames 
(ORFs) included in the model. The schematic diagram of the model 
development and its applications is schematically illustrated in Figure 
3. In brief, the metabolic network reconstruction of A. platensis strain 
C1 was initially started with automated construction using Pathway 
Tools software [52] to generate a draft metabolic network. This 
automated construction facilitates the top-down reconstruction 
approach which rapidly gives an overview network and visualization. 
Certainly, the quality of the large-scale reconstructed network depends 
on the quality of the initial annotated data. Hence, manual annotation 
was subsequently performed to increase the accuracy of the draft auto-
generated network. Nonetheless, there are still a number of 
incomplete pathways (i.e. missing genes and reactions) indicating 
disconnections in the network. Missing reactions (referred to gaps) 
that resulted in dead-end metabolites and prevented the model 
simulation of cell growth were then identified. Therefore, an 
additional step for metabolic network refinement of A. platensis strain 
C1 was performed based on present information about cyanobacteria 
from biochemical literature, biochemistry textbooks, and online 
biochemical databases. In order to complete the pathways where no 
gene could be found in the metabolic reconstruction, the Blast 
algorithms and the advanced tools for the protein domain prediction 
against Pfam database were further used to determine the enzymatic 
gene functions of A. platensis strain C1. Towards the end, the refined 
metabolic network of A. platensis strain C1 contained 692 metabolic 
genes, 658 metabolites, and 688 biochemical reactions [51]. Then, a 
stoichiometric model for flux balance analysis (FBA) modeling was 
formulated to investigate and predict the cellular physiology of 
Arthrospira. The stoichiometric model was employed for studying the 
metabolic states of A. platensis strain C1 under autotrophic, 
heterotrophic, and mixotrophic growth conditions. Interestingly, 
iAK692 model-based FBA was shown to correspond with the 
fermentation experiments during autotrophy, heterotrophy, and 
mixotrophy. In addition to the growth studies, the topological 
network analysis was then performed in order to reveal metabolic 
network properties of the iAK692 model. Through this topological 
analysis, the model could allow the large-scale in silico gene deletion 
and reaction activity analysis for a specific growth condition. In 
addition, iAK692 was employed to investigate the relationship 
between photosynthesis and respiration during Arthrospira growth by 
using phenotype phase plane analysis (PhPP). Clearly, the iAK692 
model is not only used for global understanding of physiological 
growth behaviors and product formulations, but also as a platform for 
systems biology investigation leading to metabolic engineering and 
strain improvement [53] towards a diverse range of biotechnological  
abilities of Arthrospira. 
 Genome-scale metabolic models provide an additional  
framework for direct  integration and analysis with high throughput-
omics data and bridge the gap between knowledge of observed 
experiment and global metabolic network structure [54, 55]. These 
advantages of genome-scale metabolic models therefore allow us to 
investigate all possible behaviors of the cellular systems responding to 
environmental changes. Certainly, a new strategy for strain 
improvement and biological process development for Arthrospira can 
be further identified. 
In addition to the recent iAK692 model, there were different 
versions of smaller-scale metabolic models earlier reconstructed for 
Arthrospira as illustrated in Figure 4. Halfway through 2003, Cogne 
et al. [56] constructed the first small-scale metabolic network of 
Arthrospira  based  only on data collection from literature and 
experimental data comprising biological pathways and cell physiology 
evidences.  Cogne’s metabolic network contained 121 reactions and 
134 metabolites which were distributed into central carbon 
metabolism (i.e. glycolysis, pentose phosphate pathway and TCA 
cycle) and abundant anabolism reactions leading to biomass 
constitution, exopolysaccharide (EPS) production, and energy aspects. 
Once Cogne’s metabolic network was converted into a stoichiometric  
Arthrospira cell factories 
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model, metabolic flux analysis was performed for quantitative analysis 
of growth under autotrophy. Interestingly, Cogne et al. found that the 
metabolic model revealed metabolic constraints with respect to 
NADH and H+ balances leading to the maximal yield of the 
Arthrospira growth-associated EPS.  
 
 
 
 
 
 
 
 
Shortly after the Cogne et al. model, another version of a small-
scale metabolic network of Arthrospira was reconstructed by Meechai 
et al.,[57] with the overall purpose aimed at a GLA synthesis pathway.  
Meechai’s metabolic network reconstruction was initially carried out 
with only literature and experimental data.  It contained 22 reactions 
and 17 metabolites [57] which were involved in the central carbon 
metabolism, the anaplerotic pathway, the photosynthesis, the GLA 
synthesis pathway and the biomass synthesis pathway. After Meechai’s 
stoichiometric model was formulated, the metabolic flux analysis was 
performed for overall metabolic distribution studies in the GLA 
synthesis pathway between wild-type and mutant strains. Once the 
model was validated with the physiological data, wild-type BP and a 
high-GLA producing mutant strain Z19/2 were experimentally 
studied on the GLA synthesis pathway. Meechai’s model suggests that 
a metabolic reaction converting acetyl-CoA into malonyl-CoA is a 
bottleneck for GLA synthesis of Arthrospira. Moreover, the model 
suggests the addition of simulation factors, such as NADPH and 
MgCl2, which resulted in higher GLA production rates in the wild-
type strain.  
 
4. Perspective and future direction on Arthrospira cell factories 
 
Needless to say, Arthrospira are attractive cyanobacteria to be 
used as efficient cell factories for the production of many valuable 
compounds useful for food, feed, fuel and pharmaceutical industries. 
This presents a grand challenge for the researchers to realize the 
enormous biotechnological potential of Arthrospira. Unfortunately, a 
stable and reliable system for efficiently transferring exogenous genes 
into Arthrospira is not yet available, thus the use of Arthrospira as cell 
factories is still limited. Nevertheless, much progress has been made in 
developing systems for gene manipulation in the Arthrospira species. 
For instance, a system for gene manipulation by certain restriction 
endonuclease enzymes were identified and characterized in A. 
platensis [58, 59].  In addition, a transformation using a natural Tn5 
transposase-transpon-cation liposome complex with electroporation 
that efficiently transferred chloramphenicol acetyltransferase gene to 
A. platensis strain C1 (PCC9438) has been reported [60]. The 
Figure 3. A schematic diagram of the development and applications of the first genome-scale model of Arthrospira, iAK692. 
 
Figure 4. Development of metabolic models of A. platensis. Each box 
represents a summary of a name and scope of a metabolic model. The 
number of metabolites (blue bar), reactions (red bar), and genes (green 
bar) are shown. 
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limited successful establishment of the genetic transformation system 
is mainly attributed to the defense mechanism systems found in 
Arthrospira such as restriction and modification enzymes (RM) as 
well as CRISPR [47]. Hence, the developing area of the strategies and 
genetic tools for manipulation of these cyanobacteria are crucial for 
further success of genetic engineering efforts.   
The increasing availability of whole genome sequences and the 
present knowledge relating to Arthrospira's metabolic and regulatory 
systems allow the researchers to gain insights into this organism at the 
systematic levels. This knowledge can now be used to address 
biological meanings and answers through possible biological 
questions, such as how the transformation systems in Arthrospira 
work in terms of function and which alternative ways can be used to 
establish novel genetic tools for genetic manipulation of Arthrospira. 
For example, thorough analysis of the Arthrospira genome sequence 
would provide an in-depth understanding of its unique RM systems, 
thereby enabling the development of efficient transformation 
strategies. For instance, with proper design and modification of an 
exogenous gene, the RM defense mechanism can be avoided, and thus 
a stable transformation can be achieved. Additionally, the recently 
published genome-scale metabolic model of A. platensis has also been 
used as a systems biology platform for analyzing A. platensis high-
throughput data at both transcriptomics and proteomics levels within 
the metabolic context. In the future, once the bioinformatics 
algorithms, the mathematical models and the Arthrospira phenotypic 
characterization of different mutants suited for metabolic engineering 
have advanced, new findings by the genome-scale model shall certainly 
pave a way for comprehensive studies of cellular systems, as well as the 
development of desirable Arthrospira cell factories for various 
industrial applications. Beyond this, we look forward to expand and 
develop the biotechnological potential of Arthrospira as biological 
factories for applied use in a greener era. 
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